Handmade quality · Free shipping over $75 · Explore the atelier

A-71915 TFA erutroban ITF2357 decreases surface CXCR4 and

SKU: 63983516903

4.2
USD119.00 USD146.00

Pay in 4 interest-free payments of $29.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro

Smiles: COC1=CC2=C(NC3=CC=C(Br)C=C3F)N=CN=C2C=C1OCC1CCN(C)CC1

PubMed Central PMCID: PMC5011721

InChiKey: OLIIUAHHAZEXEX-UHFFFAOYSA-N

A-71915 TFA erutroban ITF2357 decreases surface CXCR4 andA 71915 (TFA) is a selective inhibitor of ANP receptor (atrial natriuretic peptide receptor), induces apoptosis and decreases insulin secretion in RINm5F pancreatic cells. Product information Molecular Weight: 1727. 98 Formula: C71H117F3N26O17S2 Chemical Name: 2, 2, 2 trifluoroacetic acid 2 ((6R, 7R, 11R, 14S, 23R, 26S, 29S, 32S, 35S, 43aR) 11 ((S) 2 amino 5 ((diaminomethylene)amino)pentanamido) 26, 35 di((S) sec butyl) 6 carbamoyl 14

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products